LAURA GIOVANNOLI: Open Payments
NPI 1598007536 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 45 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,526 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $178 |
| ABBVIE INC. | 10 | $173 |
| Exact Sciences Corporation | 4 | $81 |
| Novo Nordisk Inc | 4 | $79 |
| PFIZER INC. | 3 | $65 |
| ACADIA Pharmaceuticals Inc | 2 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $54 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Lilly USA, LLC | 2 | $37 |
| Corcept Therapeutics | 2 | $30 |
Products named: BREZTRI, Cologuard Collection Kit, UBRELVY, QULIPTA, FARXIGA, NUPLAZID, Ozempic, Kerendia.
Industry payments across CT — which companies pay providers there.
